• Return to Headlines

Biomarin Pharmac is Among the Companies in the Biotechnology Industry With the Highest EBITDA Growth (BMRN, MDXG, ALXN, CELG, RGEN)

By Shiri Gupta

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks highest with a EBITDA growth of 156.0%. Following is Mimedx Group Inc with a EBITDA growth of 140.6%. Alexion Pharm ranks third highest with a EBITDA growth of 121.4%.

Celgene Corp follows with a EBITDA growth of 116.7%, and Repligen Corp rounds out the top five with a EBITDA growth of 103.7%.

SmarTrend recommended that subscribers consider buying shares of Repligen Corp on February 22nd, 2018 as our technology indicated a new Uptrend was in progress when shares hit $34.93. Since that recommendation, shares of Repligen Corp have risen 41.1%. We continue to monitor Repligen Corp for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest ebitda growth biomarin pharmac mimedx group inc alexion pharm celgene corp repligen corp

Ticker(s): BMRN MDXG ALXN CELG RGEN